Unlike skin, oral gingival do not scar in response to tissue injury. Fibroblasts, the cell type responsible for connective tissue repair and scarring, are exposed to mechanical tension during normal and pathological conditions including wound healing and fibrogenesis. Understanding how human gingival fibroblasts respond to mechanical tension is likely to yield valuable insights not only into gingival function but also into the molecular basis of scarless repair. CCN2/connective tissue growth factor is potently induced in fibroblasts during tissue repair and fibrogenesis. We subjected gingival fibroblasts to cyclical strain (up to 72 hours) using the Flexercell system and showed that CCN2 mRNA and protein was induced by strain. Strain caused the rapid activation of latent TGFβ, in a fashion that was reduced by blebbistatin and FAK/src inhibition, and the induction of endothelin (ET-1) mRNA and protein expression. Strain did not cause induction of α-smooth muscle actin or collagen type I mRNAs (proteins promoting scarring); but induced a cohort of pro-proliferative mRNAs and cell proliferation. Compared to dermal fibroblasts, gingival fibroblasts showed reduced ability to respond to TGFβ by inducing fibrogenic mRNAs; addition of ET-1 rescued this phenotype. Pharmacological inhibition of the TGFβ type I (ALK5) receptor, the endothelin A/B receptors and FAK/src significantly reduced the induction of CCN2 and pro-proliferative mRNAs and cell proliferation. Controlling TGFβ, ET-1 and FAK/src activity may be useful in controlling responses to mechanical strain in the gingiva and may be of value in controlling fibroproliferative conditions such as gingival hyperplasia; controlling ET-1 may be of benefit in controlling scarring in response to injury in the skin.
Unlike skin, oral gingival do not scar in response to tissue injury. Fibroblasts, the cell type responsible for connective tissue repair and scarring, are exposed to mechanical tension during normal and pathological conditions including wound healing and fibrogenesis. Understanding how human gingival fibroblasts respond to mechanical tension is likely to yield valuable insights not only into gingival function but also into the molecular basis of scarless repair. CCN2/connective tissue growth factor is potently induced in fibroblasts during tissue repair and fibrogenesis. We subjected gingival fibroblasts to cyclical strain (up to 72 hours) using the Flexercell system and showed that CCN2 mRNA and protein was induced by strain. Strain caused the rapid activation of latent TGFβ, in a fashion that was reduced by blebbistatin and FAK/src inhibition, and the induction of endothelin (ET-1) mRNA and protein expression. Strain did not cause induction of α-smooth muscle actin or collagen type I mRNAs (proteins promoting scarring); but induced a cohort of pro-proliferative mRNAs and cell proliferation. Compared to dermal fibroblasts, gingival fibroblasts showed reduced ability to respond to TGFβ by inducing fibrogenic mRNAs; addition of ET-1 rescued this phenotype. Pharmacological inhibition of the TGFβ type I (ALK5) receptor, the endothelin A/B receptors and FAK/src significantly reduced the induction of CCN2 and pro-proliferative mRNAs and cell proliferation. Controlling TGFβ, ET-1 and FAK/src activity may be useful in controlling responses to mechanical strain in the gingiva and may be of value in controlling fibroproliferative conditions such as gingival hyperplasia; controlling ET-1 may be of benefit in controlling scarring in response to injury in the skin.
Fibrosis is the formation of excessive connective tissue in a reparative or reactive
process. Scars are areas of fibrosis that replace normal tissue after injury;
excessive scarring can obliterate tissue architecture, culminating culminate in
organ failure and death. Scarring in response to wounding occurs in skin, but not in
the oral cavity [1]. Fibroblasts, which are embedded within connective tissue, are
the cell type responsible for connective tissue repair and fibrosis [2], and thus it is
reasonable to hypothesize that differences in response of gingival and dermal
fibroblasts to fibrogenic stimuli are likely to underlie the basis of scarless
tissue repair.One such fibrogenic stimulus may be mechanical tension. Although most tissues exist
under a mechanical tension, resident fibroblasts are normally
‘stress-shielded’ by the matrix that they deposit and remodel and thus
are protected from the external loads by the mechanical properties of the
surrounding matrix; however, this protection is lost during injury [3]. Indeed,
fibroblasts are subjected to alterations in mechanical during physiological as well
as pathological situations, such as wound healing, development of hypertrophic
scars, and fibrogenesis. The effect of mechanical forces on gene regulation have
been mainly studied in endothelial and smooth muscle cells or chondrocytes that are
constantly subjected to high fluid shear or pressure loading [4]; however, one study showed that
application of strain to dermal fibroblasts resulted in their differentiation of
myofibroblasts, as visualized by the induction of collagen type I and α-smooth
muscle actin (α-SMA) [5], the key cell type responsible for scarring [6]. Conversely, the
responses of gingival fibroblasts to mechanical loading are almost wholly unknown,
which is perhaps surprising since orthodontic forces are constantly affecting the
extracellular matrix (ECM) and the cells within dental pulp, periodontal ligament,
alveolar bone, and gingiva [7]–[9]. Indeed, it has been hypothesized that application of
external mechanical loads to teeth may alter the forces acting on gingival
fibroblasts, leading to changes in gene expression ultimately culminating in
alteration in the structure and function of the ECM [7]; however, this hypothesis has
yet to be tested. Thus understanding how gingival fibroblasts respond to mechanical
loading is therefore necessary to not only understand how these cells respond to
normal orthodontic forces, but may also reveal valuable insights into the potential
molecular basis of scarless tissue repair.The protein connective tissue growth factor (CTGF/CCN2), a member of the CCN (Cyr61,
ctgf, nov) family of matricellular proteins, is potently induced by fibrogenic
protein transforming growth factor (TGF)β [10], [11]. CCN2 expression correlates well
with the onset of tissue repair and fibrotic conditions, including those affecting
the oral cavity such as phenytoin-induced gingival overgrowth or hereditary gingival
fibromatosis [10]–[15], and appears to contribute to collagen deposition in
these processes; for example, mice deficient in CCN2 expression in dermal
fibroblasts are resistant to bleomycin-induced skin fibrosis [16]. CCN2 has been shown to respond to
mechanical strain in a bladder and endothelial cells [17], [18], but whether CCN2 is induced
in response to strain in gingival fibroblasts is not known. Examining the control of
CCN2 expression in response to strain in gingival fibroblasts is therefore likely to
represent a useful tool in understanding the molecular mechanism underlying the
ability of strain to modulate gene expression in gingival fibroblasts.In this report, we investigate of mechanical strain on gene expression in gingival
fibroblasts by monitoring the alterations in (a) CCN2 expression using real-time
polymerase chain reaction and Western blot analyses and (b) genome-wide mRNA
expression using micro-array profiling. Our results not only give new and valuable
insights into the molecular mechanism underlying how gingival fibroblasts respond to
strain and but may also have long-term consequences for understanding how to
modulate gene expression in pathological conditions such as gingival hyperplasia and
also in understanding the potential mechanism underlying scarless repair in the oral
cavity.
Methods
Cell Culture
Gingival fibroblasts from three human donors (HGF) were used for this study and
were identical to those previously described [14]. Cells were cultured in
DMEM, supplemented with 10% fetal bovine serum, 1%
antibiotic-antimycotic (Invitrogen), in a humidified 5% CO2 at
37°C. All experiments were performed on cells between passage 5 and 7. Human
dermal fibroblasts (HDF) were purchased (ATCC) and cultured identically.
Mechanical stress
HGF (1×105) were cultured on 6 well plates with a flexible,
silicon-based well that was coated with type I collagen (Flexcell), and then
subjected to 10% uniaxial cyclic strain at 0.5 Hz for up to 72 hours
using a Flexercell apparatus (Flexcell). Parameters were chosen based on their
ability to maximally induce CCN2 mRNA. Controls were prepared in an identical
manner and cultured on unstrained type I collagen-coated plates. For inhibitors
treatment, hGF were rendered quiescent by 24-hour incubation in DMEM with
0.5% FBS. Inhibitors of the TGFβ type I (ALK5) receptor (SB431542; 10
µM; please note that this inhibitor also affects the activin type I
receptor ALK4 and the nodal type I receptor ALK7), FAK/src (PP2; 10 µM),
ETA/B receptor (PD145065; 10 µM), the actin/myosin destabilizing agent
blebbistatin (12.5 µM) (all purchased from Calbiochem) or DMSO control was
then added to the culture medium before subjected to mechanical stretch. These
concentrations of inhibitors have been previously shown to be effective and
selective for their respective targets [19]–[24]. When indicated, conditioned
culture supernatants or cell layers were isolated for protein or mRNA
analysis.
TGFβ1 stimulation
HGF and HDF cells were cultured on 6 well plates (plastic, Greiner Bio-one) until
60% confluent, serum-starved (DMEM, 0.5% FBS) for 24 hours and
then treated with or without TGFβ1 (4 ng/ml; R and D Systems) for an
additional 6 hours prior to RNA extraction. For rescue experiment, cells were
similarly cultured and preincubated with or without endothelin-1 (ET-1, 100 nM;
R and D Systems) for 30 min prior to the incubation with or without TGFβ1
for additional 6 hours.
Real-time polymerase chain reaction
Real-time PCR was performed as previously described [14], [25]. Total RNA was isolated
(Trizol, Invitrogen) and then was reverse transcribed and amplified using TaqMan
Assay-on-Demand (Applied Biosystems) in a 15-µl reaction volume containing
2 unlabeled primers and a 6-FAM–labeled TaqMan minor groove binder.
Samples were combined using One-Step Master Mix (Applied Biosystems), and
amplified sequences were detected using the ABI Prism 7900HT Sequence Detector
(Perkin-Elmer-Cetus) according to the manufacturer's instructions.
Triplicate samples were run. Expression values were standardized to values
obtained with control 18S RNA primers, using the 2-ΔΔCt
method.
ELISA assays
The concentration of active TGFβ1 in the cell culture supernatants was
measured using TGFβ1 Emax® ImmunoAssay System (Promega). For active
TGFβ1, 100 µl culture supernatants were used in the Emax immunoassay,
which was performed according to the manufacture's instructions [26]. The
standard curve is linear between 15.6 and 1,000 pg/ml of the TGFβ1 standard.
TGFβ1 standard curves were undertaken for every assay. All experiments were
performed in triplicate. The data are represented as the mean values of these
triplicate samples.The secreted endothelin-1 (ET-1) level in the culture supernatants was determined
in triplicate using a Quantiglo HumanEndothelin-1 Immunoassay (R&D
Systems). 100 µl culture supernatants were used in the Quantiglo
immunoassay, which was performed according to the manufacturer's
instructions. The standard curve is linear between 0.34 and 250 pg/ml of the
endothelin-1 standard and was conducted for every assay.
Western Blotting
Samples containing 100 µg of protein were subjected to SDS-PAGE and then
transferred to PVDF membranes (Invitrogen). The membranes were blocked with
5% milk-TBST for 1 hour at room temperature, incubated with anti-CCN2
antibody (Santa Cruz, 1∶200 dilution) overnight at 4°C, washed with
TBST, incubated with secondary goat anti-mouse antibody (Jackson Immunoresearch,
1∶10000) conjugated to horseradish peroxidase, washed and visualized with
ECL Western Blotting Detection Reagents (Amersham Biosciences). After stripping
with Restore Western Blot Stripping Buffer (Pierce) for 20 minutes at room
temperature, membranes were processed similarly with β-actin antibody
(Sigma, 1∶10000 dilution) as a loading control.
Expression Profiling
Expression profiling was conducted essentially as previously described [27], [28]. All sample
labeling and GeneChip processing was performed at the London Regional Genomics
Centre (Robarts Research Institute, London, Ontario, Canada; http://www.lrgc.ca). RNA quality was assessed using the Agilent
2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA) and the RNA 6000
Nano kit (Caliper Life Sciences, Mountain View, CA). Single stranded
complimentary DNA (sscDNA) was prepared from 200 ng of total RNA as per the
Ambion WT Expression Kit for Affymetrix GeneChip Whole Transcript WT Expression
Arrays (http://www.ambion.com/techlib/prot/fm_4411973.pdf, Applied
Biosystems, Carlsbad, CA) and the Affymetrix GeneChip WT Terminal Labeling kit
and Hybridization User Manual (http://media.affymetrix.com/support/downloads/manuals/wt_term_label_ambion_user_manual.pdf,
Affymetrix, Santa Clara, CA). Total RNA was first converted to cDNA, followed by
in vitro transcription to make cRNA. 5.5 µg of single
stranded cDNA was synthesized, end labeled and hybridized, for 16 hours at
45°C, to Human Gene 1.0 ST arrays. All liquid handling steps were performed
by a GeneChip Fluidics Station 450 and GeneChips were scanned with the GeneChip
Scanner 3000 7G (Affymetrix, Santa Clara, CA) using Command Console v1.1. Probe
level (.CEL file) data was generated using Affymetrix Command Console v1.1.
Probes were summarized to gene level data in Partek Genomics Suite v6.5 (Partek,
St. Louis, MO) using the RMA algorithm. Partek was used to determine gene level
ANOVA p-values, fold changes and GO (Gene Ontology) enrichment, using a Chi
squared test. Experiments were performed twice, and fold changes were identified
using the GeneSpring filter. The fold change between with and without mechanical
strain treatment had to be at least 1.5 fold to identify a transcript as being
altered (p<0.05) and these genes list was compiled and exported into DAVID
(http://david.abcc.ncifcrf.gov/) for further analysis.
Proliferation assay
Gingival fibroblasts were seeded on type I collagen-coated plate at a density of
50,000 cells per well. After 24 hour of serum-starvation (DMEM, 0.5%
FBS), DMSO or TGFβ type I (ALK5) receptor (SB431542; 10 µM), FAK/src
(PP2; 10 µM) or ETA/B receptor (PD145065; 10 µM) inhibitor was added
to the culture medium. Cells were then subjected to 10% uniaxial cyclic
strain at 0.5 Hz for 72 hours using a Flexercell apparatus (Flexcell). Controls
were prepared in the same way and cultured on an unstrained type I
collagen-coated plate. After 72 hours stretch, cells underwent evaluation for
proliferation using an MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay,
which indirectly measures cell proliferation by assessing metabolic activity, as
described by the manufacturer (Roche). Briefly, cells were washed twice with
PBS, and l.5 ml of serum-free medium containing 100 µg/ml MTT was added to
each well. After incubation at 37°C for 4 h, 1.5 ml solubilization solution
was added to dissolve MTT crystals overnight. Two hundred microlitres of
solution from each well were transferred into 96-well microplate and measured
for absorbance at 570 nm with reference at 680 nm.
Statistical Analysis
Statistical tests were done using one-way ANOVA analysis of variance and
Tukey's post hoc test with GraphPad Software V.4 (Graphpad
Software, La Jolla, CA, USA). P values less than 0.05 were taken to be
significant.
Results
CCN2/CTGF mRNA and protein are induced in response to strain in human
gingival fibroblasts
Because of the known utility of CCN2 as a molecular marker of tissue repair and
fibrogenic responses [10], [15], we were initially interested in examining whether
mechanical strain could induce CCN2 mRNA expression in gingival fibroblasts. To
perform this analysis, we used the Flexercell system, employing 6-well tissue
culture plates possessing silicon membranes coated with type I collagen. Equal
numbers of cells were placed on tissue culture plates and treated with or
without strain (10% uniaxial cyclic strain, 0.5 Hz) for up to 72 hours.
Cells from three separate individuals were used for our analyses. Real time PCR
analysis of total RNA extracted from these cells revealed that, after
application of strain for 72 hours, CCN2 mRNA was statistically significantly in
cells subjected to strain, relative to cells that were not subjected to strain
for the same duration (Fig.
1). Similar results when cells were cultured on laminin-coated plates
(not shown). Intriguingly, mRNA expression of neither collagen type I (Col 1a2)
nor α-SMA was altered by strain (Fig. 1).
Figure 1
Mechanical strain induces CCN2/CTGF mRNA expression in human gingival
fibroblasts (HGF).
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes and subjected to the presence or absence of mechanical strain
for up to 72 hours. Total RNA was harvested, and subjected to real-time
PCR analysis with primers detecting CCN2, collagen type I (Col1a2) or
α-SMA. Expression values are adjusted to those of controls (18S) run
in parallel. Experiments were performed on cells derived from three
different individuals, with quadruplicate replicate samples. Relative
expression at time zero (control) was taken to represent 1. Fold
increase in relation to time zero (control) is shown. Data shown are the
average value from three independent individuals (3 replicates
per experiment) ±SE.
** = p<0.01. Note that α-SMA and
Col1a2 mRNAs were not significantly induced by strain. Similar results
were obtained if cells were plated on laminin-coated membranes (not
shown).
Mechanical strain induces CCN2/CTGF mRNA expression in human gingival
fibroblasts (HGF).
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes and subjected to the presence or absence of mechanical strain
for up to 72 hours. Total RNA was harvested, and subjected to real-time
PCR analysis with primers detecting CCN2, collagen type I (Col1a2) or
α-SMA. Expression values are adjusted to those of controls (18S) run
in parallel. Experiments were performed on cells derived from three
different individuals, with quadruplicate replicate samples. Relative
expression at time zero (control) was taken to represent 1. Fold
increase in relation to time zero (control) is shown. Data shown are the
average value from three independent individuals (3 replicates
per experiment) ±SE.
** = p<0.01. Note that α-SMA and
Col1a2 mRNAs were not significantly induced by strain. Similar results
were obtained if cells were plated on laminin-coated membranes (not
shown).
Strain results in elevated TGFβ activity and expression in gingival
fibroblasts
The kinetics of CCN2 induction in response to mechanical stain suggested that
strain indirectly resulted in increased CCN2 expression (Fig. 1). Contraction of ECM by skin and lung
fibroblasts causes activation of latent TGFβ via integrins; this activation
is blocked by the actin/myosin destabilizing agent blebbistatin which blocks ECM
contraction by fibroblasts [24], [29], [30]. Based on these observations, we hypothesized that
mechanical strain could elevate CCN2 mRNA and protein in gingival fibroblasts
indirectly via the ability of strain to induce activation of TGFβ. To begin
to investigate this hypothesis, we used specific ELISAs to show that strain (24
hours) could induce the appearance of activated TGFβ; total TGFβ levels
were unaltered (Fig. 2).
This increase in activated TGFβ was significantly reduced by the
actin/myosin depolymerizing agent blebbistain (Fig. 2). Focal adhesions mediate the
interaction of integrins with the ECM; inhibition of focal adhesion kinase
(FAK)/src with PP2 (10 µM) significantly reduced the ability of strain to
induce activation of TGFβ (Fig.
2). Collectively, these data suggest the involvement of contraction
in this process.
Figure 2
Strain induces the activation of latent TGFβ in human gingival
fibroblasts.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 24
hours. As described in methods, ELISA was used to detect total and
activated TGFβ in the presence or absence of DMSO, blebbistatin
(which blocks activation of TGFβ by impairing actin/myosin-dependent
cell contraction [24], [29], [30]) or
the FAK/src inhibitor PP2. Note induction of active TGFβ at the 24
hour time-point in the presence of strain and DMSO relative to cells
treated with blebbistatin, strain and PP2, and control cells not
subjected to strain. Data shown are the average value from three
independent individuals (3 replicates per experiment)
±SE. ** = p<0.01.
Strain induces the activation of latent TGFβ in human gingival
fibroblasts.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 24
hours. As described in methods, ELISA was used to detect total and
activated TGFβ in the presence or absence of DMSO, blebbistatin
(which blocks activation of TGFβ by impairing actin/myosin-dependent
cell contraction [24], [29], [30]) or
the FAK/src inhibitor PP2. Note induction of active TGFβ at the 24
hour time-point in the presence of strain and DMSO relative to cells
treated with blebbistatin, strain and PP2, and control cells not
subjected to strain. Data shown are the average value from three
independent individuals (3 replicates per experiment)
±SE. ** = p<0.01.
CCN2/CTGF is induced in response to strain via a TGFβ type I receptor
(ALK5)-dependent mechanism
To address whether the increase in CCN2 expression in response to strain was
dependent on TGFβ, we initially performed real-time PCR analysis on mRNAs
treated with or without mechanical strain for 72 hours. This time point was
chosen as previously we had determined that CCN2 mRNA was induced 72
hours-post-strain, but not at earlier timepoints (Fig. 1). We found that inhibition of the
TGFβ type I (ALK5) receptor (SB431542; 10 µM) or FAK/src (PP2; 10
µM) significantly blocked the ability of strain to induce CCN2 mRNA and
protein in gingival fibroblasts (Fig. 3A, B). Moreover, consistent with the notion that
loading/contraction-mediated activation of TGFβ resulted in the elevation of
CCN2 expression, blebbistatin reduced the ability of strain to induce CCN2 mRNA
and protein in gingival fibroblasts (Fig. 3A, B). Collectively, our data suggest
that exposure of cyclic mechanical strain to gingival fibroblasts indirectly
causes the induction of CCN2 through increased activation of latent
TGFβ.
Figure 3
The ability of strain to induce CCN2 expression in blocked by ALK5 or
ETA/B receptor inhibition.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were treated with or without DMSO, the ALK5 inhibitor
SB431542, PP2, blebbistatin or the ETA/B receptor antagonist PD145065,
as indicated. (A) Total RNA was harvested, and subjected to real-time
PCR analysis with primers detecting CCN2. Expression values are adjusted
to those of controls (18S) run in parallel. Experiments were performed
on cells derived from three different individuals, with quadruplicate
replicate samples. (B) Cells were treated with or without DMSO, the ALK5
inhibitor SB431542, PP2, blebbistatin or the ETA/B receptor antagonist
PD145065, as indicated. Total protein was harvested, and subjected to
Western blot analysis with anti-CCN2 or anti-β-actin antibodies, as
indicated. Data shown are the average value from three independent
individuals (3 replicates per experiment) ±SE.
* = p<0.05;
** = p<0.01.
The ability of strain to induce CCN2 expression in blocked by ALK5 or
ETA/B receptor inhibition.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were treated with or without DMSO, the ALK5 inhibitor
SB431542, PP2, blebbistatin or the ETA/B receptor antagonist PD145065,
as indicated. (A) Total RNA was harvested, and subjected to real-time
PCR analysis with primers detecting CCN2. Expression values are adjusted
to those of controls (18S) run in parallel. Experiments were performed
on cells derived from three different individuals, with quadruplicate
replicate samples. (B) Cells were treated with or without DMSO, the ALK5
inhibitor SB431542, PP2, blebbistatin or the ETA/B receptor antagonist
PD145065, as indicated. Total protein was harvested, and subjected to
Western blot analysis with anti-CCN2 or anti-β-actin antibodies, as
indicated. Data shown are the average value from three independent
individuals (3 replicates per experiment) ±SE.
* = p<0.05;
** = p<0.01.
The ability of strain to induce CCN2 depends on signaling through the
endothelin A/B (ETA/B) receptors
Endothelin-1 (ET-1), which signals through the ETA/B receptors, is a potent
vasoconstrictory peptide that can act both downstream and concomitant with
TGFβ to activate fibrogenic gene expression [31]–[33]. To assess whether ET-1 was
involved with the ability of strain to induce CCN2, we first used real-time PCR
and a specific ELISA to show that strain induced ET-1 mRNA (Fig. 4A) and protein (Fig. 4B) expression in a fashion that was
sensitive to ALK5 inhibition. Moreover, consistent with the notion that
loading/contraction-mediated activation of TGFβ resulted in the elevation of
endothelin-1 expression, blebbistatin and PP2 reduced the ability of strain to
induce ET-1 mRNA and protein in gingival fibroblasts (Fig. 4A, B). Having shown that strain could
induce ET-1, we then used real time PCR and Western blot analyses to show that
the ETA/B receptor inhibitor PD145065 (10 µM) could significantly reduce
the ability of strain to elevate CCN2 mRNA and protein levels (Figs. 3A, B). These data
suggest that strain induces CCN2 production in a fashion dependent on (a) the
ability of strain to activate latent TGFβ via a actin/myosin and FAK/src
dependent mechanism (contraction) and (b) on the ability of TGFβ to elevate
ET-1 production.
Figure 4
Strain induces endothelin-1 (ET-1) production.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were treated with or without DMSO, the ALK5 inhibitor
SB431542, PP2, or blebbistatin, as indicated. (A) Total RNA was
harvested, and subjected to real-time PCR analysis with primers
detecting ET-1. Expression values are adjusted to those of controls
(18S) run in parallel. Experiments were performed on cells derived from
three different individuals, with quadruplicate replicate samples. (B)
Conditioned media was subjected to ELISA to detect ET-1. Data shown are
the average value from three independent individuals (3 replicates
per experiment) ±SE.
* = p<0.05;
** = p<0.01.
Strain induces endothelin-1 (ET-1) production.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were treated with or without DMSO, the ALK5 inhibitor
SB431542, PP2, or blebbistatin, as indicated. (A) Total RNA was
harvested, and subjected to real-time PCR analysis with primers
detecting ET-1. Expression values are adjusted to those of controls
(18S) run in parallel. Experiments were performed on cells derived from
three different individuals, with quadruplicate replicate samples. (B)
Conditioned media was subjected to ELISA to detect ET-1. Data shown are
the average value from three independent individuals (3 replicates
per experiment) ±SE.
* = p<0.05;
** = p<0.01.
Gingival fibroblasts are less responsive to TGFβ than dermal fibroblasts;
addition of ET-1 to gingival fibroblasts rescues this phenotype
It was interesting that whereas mechanical strain induced TGFβ activation,
ET-1 and CCN2 and TGFβ mRNAs, but not type I collagen or αSMA mRNAs,
were induced. This result suggested the intriguing possibility that gingival
fibroblasts were relatively unable to respond to TGFβ by inducing type I
collagen or αSMA mRNAs. To further explore this notion, we compared the
responses of gingival and dermal fibroblasts to TGFβ1. We showed that
TGFβ1 (4 ng/ml, 6 hours) caused potent induction of CCN2, collagen I and
αSMA mRNAs in human dermal fibroblasts (Fig. 5A). Note that of these mRNAs, CCN2 mRNA
was the transcript that was most highly induced by TGFβ1. Conversely, human
gingival fibroblasts were less responsive to TGFβ1 (4 ng/ml, 6 hours). These
results indicate that the basis for the inability of strain to induce type I
collagen and α-SMA mRNAs was likely to arise due to the relative inability
of gingival fibroblasts to respond to TGFβ by inducing these mRNAs.
Figure 5
Human gingival fibroblasts are less sensitive to TGFβ1 than human
dermal fibroblasts and addition of ET-1 rescued this phenotype.
(A) Equal numbers of human gingival fibroblasts (HGF) and human dermal
fibroblasts (HDF) of equal passage were plated onto tissue culture
plates (plastic) and treated with or without TGFβ1 (4 ng/ml) for 6
hours. Total RNA was harvested, and subjected to real-time PCR analysis
with primers detecting CCN2, collagen type I (Col1a2) or α-SMA.
Expression values are adjusted to those of controls (18S) run in
parallel. (B) HGF and HDF cells were plated onto tissue culture plates
(plastic), both cells and cell culture supernatants were harvested.
Total RNA were extracted and subjected to real-time PCR analysis with
primers detecting ET-1. Expression values are adjusted to those of
controls (18S) run in parallel. Cell culture supernatants were subjected
to ELISA to detect ET-1. (C) As described in Methods, cells were preincubated with or without
Endothelin 1 (100 nM; R and D Systems) for 30 min prior to the
incubation with or without TGFβ1 for additional 6 hours. Total RNA
was harvested, and subjected to real-time PCR analysis with primers
detecting CCN2, collagen type I (Col1a2) or α-SMA. Expression values
are adjusted to those of controls (18S) run in parallel. Data shown are
the average value from three independent individuals (3 replicates
per experiment) ±SE.
* = p<0.05;
** = p<0.01;
*** = p<0.001.
Human gingival fibroblasts are less sensitive to TGFβ1 than human
dermal fibroblasts and addition of ET-1 rescued this phenotype.
(A) Equal numbers of human gingival fibroblasts (HGF) and human dermal
fibroblasts (HDF) of equal passage were plated onto tissue culture
plates (plastic) and treated with or without TGFβ1 (4 ng/ml) for 6
hours. Total RNA was harvested, and subjected to real-time PCR analysis
with primers detecting CCN2, collagen type I (Col1a2) or α-SMA.
Expression values are adjusted to those of controls (18S) run in
parallel. (B) HGF and HDF cells were plated onto tissue culture plates
(plastic), both cells and cell culture supernatants were harvested.
Total RNA were extracted and subjected to real-time PCR analysis with
primers detecting ET-1. Expression values are adjusted to those of
controls (18S) run in parallel. Cell culture supernatants were subjected
to ELISA to detect ET-1. (C) As described in Methods, cells were preincubated with or without
Endothelin 1 (100 nM; R and D Systems) for 30 min prior to the
incubation with or without TGFβ1 for additional 6 hours. Total RNA
was harvested, and subjected to real-time PCR analysis with primers
detecting CCN2, collagen type I (Col1a2) or α-SMA. Expression values
are adjusted to those of controls (18S) run in parallel. Data shown are
the average value from three independent individuals (3 replicates
per experiment) ±SE.
* = p<0.05;
** = p<0.01;
*** = p<0.001.Since ET-1 can synergize with TGFβ [32], we began to
investigate whether the relative inability of gingival fibroblasts to respond to
TGFβ could be due to diminished ET-1 production. We found that, both at an
mRNA and a protein level, gingival fibroblasts showed reduced ET-1 production
(Fig. 5B). The key
feature of fibrotic cells is differentiation of fibroblasts to
α-SMA-expressing myofibroblasts [2], [3]; addition of recombinant
ET-1 to gingival fibroblasts rescued the ability of TGFβ to potently induce
CCN2 and α-SMA mRNAs in gingival fibroblasts (please note that the
relatively modest response of dermal fibroblasts by inducing collagen mRNA
precluded the use of this transcript in our rescue experiment) (Fig. 5C).
Mechanical strain induces the proliferation of gingival fibroblasts
Given that gingival fibroblasts clearly were able to respond to strain, as
visualized by their ability to support CCN2, TGFβ and ET-1 induction, we
then used genome-wide expression profiling to investigate the overall effect of
mechanical strain on gene regulation in gingival fibroblasts. Thus, genome-wide
expression profiling was conducted on gingival fibroblasts treated with or
without mechanical strain for 72 hours. RNAs were extracted, and subjected to
Affymetrix gene profiling and cluster analysis. No ‘fibrotic’
cluster was identified; however, a cluster containing genes involved with cell
proliferation was found to be induced in response to strain (Table 1). The mRNAs encoding
cdc6 and cdk6 were selected for further analysis. Cell division cycle 6 (CDC6)
is an essential regulator of DNA replication in eukaryotic cells [34] and
cyclin-dependent kinases (including cdk6) are catalytic subunits of a family of
mammalian heterodimeric serine/threonine kinases implicated in the control of
cell-cycle progression [35]. Thus these mRNAs were selected for further analysis.
Real time PCR analysis verified our gene array data that cdc6 and cdk6 were
induced in response to strain (Fig.
6A). Moreover, the induction of cdc6 and cdk6 mRNAs was reduced by
ALK5, ETA/B and FAK/src inhibition (Fig. 6B). Providing a functional context to our studies, we found
that mechanical strain (72 hours) induced proliferation of gingival fibroblasts
in a fashion which was sensitive to ALK5, ETA/B and FAK/src inhibition (Fig. 7).
Table 1
Cluster analysis of mRNA (out of 453 total) induced more than
1.5-fold by mechanical stress. Average expression value is shown.
(P<0.05).
Affymetrix ID
RefSeq
Gene name
Fold up( Stress VS Contol)
regulation of cell
cycle
8017262
NM_032043
BRCA1 interacting protein C-terminal helicase
1
BRIP1
2.49846
7986068
NM_000057
Bloom syndrome, RecQ helicase-like
BLM
2.47173
8112327
NM_001826
CDC28 protein kinase regulatory subunit 1B
CKS1B
1.94192
8071212
NM_003504
CDC45 cell division cycle 45-like
CDC45L
1.80526
8065710
NM_005225
E2F transcription factor 1
E2F1
1.56671
8130374
NM_012177
F-box protein 5
FBXO5
2.55508
8073858
NM_016426
G-2 and S-phase expressed 1
GTSE1
1.64131
7952179
NM_002105
H2A histone family, member X
H2AFX
1.69245
7924096
NM_002497
NIMA (never in mitosis gene a)-related kinase
2
NEK2
2.46098
7933707
NM_032997
ZW10 interactor
ZWINT
2.09189
8132318
NM_018685
anillin, actin binding protein
ANLN
2.86885
8010260
NM_001168
baculoviral IAP repeat-containing 5
BIRC5
1.80698
7968484
NM_000059
breast cancer 2, early onset
BRCA2
1.61286
7927710
NM_001786
cell division cycle 2, G1 to S and G2 to M
CDC2
2.75341
8007071
NM_001254
cell division cycle 6 homolog
CDC6
1.623984
8102643
NM_001237
cyclin A2
CCNA2
2.28238
8105828
NM_031966
cyclin B1
CCNB1
2.33148
8151871
NM_057749
cyclin E2
CCNE2
2.547
7956076
NM_001798
cyclin-dependent kinase 2
CDK2
2.04659
8140955
NM_001259
cyclin-dependent kinase 6
CDK6
1.55686
8116921
NM_001955
endothelin 1
EDN1
1.53003
7982889
NM_016359
nucleolar and spindle associated protein 1
NUSAP1
2.29659
8063043
NM_181802
ubiquitin-conjugating enzyme E2C
UBE2C
1.58997
Figure 6
Strain induces cdc6 and cdk6 mRNAs in human gingival
fibroblasts.
(A) As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for up to
72 hours. Total RNA was harvested, and subjected to real-time PCR
analysis with primers detecting cdc6 and cdk6 mRNAs. Expression values
are adjusted to those of controls (18S) run in parallel. (B) Experiments
similar to those performed in (A) were conducted with or without
mechanical strain (72 hours) in the presence or absence of DMSO, the
ALK5 inhibitor SB431542, PP2, blebbistatin or the ETA/B receptor
antagonist PD145065, as indicated. Total RNA was harvested, and
subjected to real-time PCR analysis with primers detecting cdc6 and cdk6
mRNAs. Expression values are adjusted to those of controls (18S) run in
parallel. Data shown are the average value from three independent
individuals (3 replicates per experiment) ±SE.
* = p<0.05;
** = p<0.01.
Figure 7
Strain induces proliferation of human gingival fibroblasts.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were harvested, and subjected to the MTT assay of cell
metabolism, an indirect method of detecting cell proliferation, as
described in methods. Cells were treated in the presence or absence of
DMSO, the ALK5 inhibitor SB431542, PP2, blebbistatin or the ETA/B
receptor antagonist PD145065, as indicated. Data shown are the average
value from three independent individuals (6 replicates per
experiment) ±SE.
** = p<0.01.
Strain induces cdc6 and cdk6 mRNAs in human gingival
fibroblasts.
(A) As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for up to
72 hours. Total RNA was harvested, and subjected to real-time PCR
analysis with primers detecting cdc6 and cdk6 mRNAs. Expression values
are adjusted to those of controls (18S) run in parallel. (B) Experiments
similar to those performed in (A) were conducted with or without
mechanical strain (72 hours) in the presence or absence of DMSO, the
ALK5 inhibitor SB431542, PP2, blebbistatin or the ETA/B receptor
antagonist PD145065, as indicated. Total RNA was harvested, and
subjected to real-time PCR analysis with primers detecting cdc6 and cdk6
mRNAs. Expression values are adjusted to those of controls (18S) run in
parallel. Data shown are the average value from three independent
individuals (3 replicates per experiment) ±SE.
* = p<0.05;
** = p<0.01.
Strain induces proliferation of human gingival fibroblasts.
As described in Methods, equal
numbers of HGF were seeded into plates containing collagen type I-coated
membranes, and were treated with or without mechanical strain for 72
hours. Cells were harvested, and subjected to the MTT assay of cell
metabolism, an indirect method of detecting cell proliferation, as
described in methods. Cells were treated in the presence or absence of
DMSO, the ALK5 inhibitor SB431542, PP2, blebbistatin or the ETA/B
receptor antagonist PD145065, as indicated. Data shown are the average
value from three independent individuals (6 replicates per
experiment) ±SE.
** = p<0.01.Collectively, these data suggest that mechanical strain induces CCN2 expression
and cell proliferation via its ability to cause activation of latent TGFβ by
a cell contraction (actin/myosin and FAK/src)-dependent mechanism.
Discussion
Our manuscript is the first to show: (a) CCN2 is induced by mechanical strain in
fibroblasts; (b) this induction occurs via TGFβ, ET-1 and FAK/src; (c) ET-1 is
induced in fibroblasts in response to strain; (d) the transcriptional response in
fibroblasts to strain depends on ET-1 and FAK/src; (e) the overall global profile of
mRNAs induced in gingival fibroblasts in response to strain; (f) strain induces a
series of pro-proliferative mRNAs and cell proliferation in gingival fibroblasts via
TGFβ, ET-1 and FAK/src; (g) that, when applied to fibroblasts, strain does not
potently induce α-SMA (a marker of myofibroblast differentiation, the key
phenotypic feature of fibrotic fibroblasts [2], [3]); (h) that, when applied to
fibroblasts, TGFβ is less potent at inducing CCN2 and α-SMA in gingival
fibroblasts compared to dermal fibroblasts; (i) gingival fibroblasts possess reduced
basal levels of ET-1 than dermal fibroblasts; and (j) application of exogenous ET-1
to gingival fibroblasts rescues the ability of TGFβ to potently induce CCN2 and
α-SMA expression.Fibrosis, the excessive production and contraction of ECM in connective tissue
resulting in scarring and often organ failure and death, is one of the largest
groups of diseases for which there is no therapy [36]. Embryos and gingiva tissue do
not scar [1].
Although it is likely that a major cause for the differences between adult and
embryonic repair, is likely to be the heightened inflammatory response that occurs
in the former situation [37], it is also reasonable to posit that differences in
fibroblast, the resident responder cell in connective tissue, responses to
fibrogenic stimuli might also be important. In this report, we showed that gingival
fibroblasts responded to strain by inducing the activation of latent TGFβ, in a
fashion which was sensitive to blebbistatin and PP2 (i.e., contraction of ECM via
actin/myosin and FAK/src), consistent with the prior observation using lung and
dermal fibroblasts that contraction (mechanical loading) of ECM induces activation
of TGFβ through an integrin/actomyosin dependent mechanism [29], [30]. However, until this report, such
a mechanism has not been shown to operate in gingival fibroblasts. Moreover, the
overall sequence starting from application of mechanical strain to the eliciting of
phenotypic alterations in gingival fibroblasts has not been elucidated until now. As
a result of strain, TGFβ, ET-1, CCN2/CTGF and proliferative mRNAs/proliferation
were induced.Fibroproliferative conditions (e.g gingival hyperplasia) are well-known to affect the
gingiva and, in these conditions, CCN2/CTGF is overexpressed [10]–[15]. Moreover, we have previously
shown that TGFβ induces CCN2 expression in gingival fibroblasts via ALK5 [14]. These
observations are consistent with our observations that gingival fibroblasts respond
to strain by inducing the expression of CCN2 as well as pro-proliferative mRNAs, and
proliferation via a TGFβ-dependent mechanism. What was surprising, and in
contrast to results previously obtained using dermal fibroblasts [5], were our
observations that neither strain nor TGFβ potently induced the expression of
α-SMA or type I collagen mRNAs. As α-SMA and type I collagen expression is a
hallmark of myofibroblast differentiation and as myofibroblasts are the cell type
believed to be responsible for scar tissue [2], [3], these differential responses
of gingival and dermal fibroblasts may underlie the basis of scarless tissue repair
in gingival fibroblasts. The precise molecular basis underlying this differential
sensitivity, at least in terms of CCN2 and α-SMA mRNAs, appeared to be due to a
decreased production of ET-1 by gingival fibroblasts. This observation is
interesting in light of previous observations, using dermal and lung fibroblasts,
that ET-1 can induce CCN2 and that ET-1 synergizes with TGFβ to induce gene
expression [32], [33]. Moreover, our data illustrating that ET-1 may be a key
fibrogenic molecule for fibroblasts are consistent with our previous observations
that ET-1 can elicit a fibrogenic response by itself and is responsible for the
persistent fibrotic phenotype of scleroderma lung fibroblasts [38]. It is interesting to note
that, although strain was able to induce ET-1 in gingival fibroblasts and elicit a
proliferative response via ET-1, similar to a recent report in which thrombin was
shown to induce proliferation in gingival fibroblasts via ET-1 [39], the level of ET-1 generated
was insufficient to potently induce CCN2 or α-SMA mRNAs.Collectively, our results suggest that mechanical tension, a key feature or normal
orthodontic forces and tissue remodeling and repair, results in the induction of
active TGFβ, CCN2 and proliferative responses but not in potent activation of
collagen type I or α-SMA mRNAs consistent with the notion that gingival do not
scar in response to wounding. CCN2, TGFβ signaling via ALK5 or activation of
latent TGFβ through ECM contraction may be useful in the future as strategies to
control the onset or progression of fibroproliferative conditions in the mouth.Until this report, the overall sequential chain of events initiated by mechanical
strain culminating in the overall cellular responses by gingival fibroblasts has not
been reported. In particular, the effect of strain on the overall gene expression
profile in gingival fibroblasts has not been disclosed. What we have shown is that
although the fundamental mechanism underlying the responses of gingival fibroblasts
to strain (involving TGFβ) may have been predicted based on individual pieces of
evidence in the literature that have been published using skin and lung fibroblasts,
what was not expected was that strain was not able to induce expression of fibrotic
mRNAs. Moreover, it was not predicted a priori that gingival fibroblasts were less
responsive to TGFβ. The fundamental basis for this reduced response was linked
to the lower production of ET-1 by gingival fibroblasts; addition of ET-1 rescued
the ability of gingival fibroblasts to respond to TGFβ. These data we feel are
important as they suggest that the fundamental basis of scarless tissue repair could
be due to the reduced production of ET-1 by gingival fibroblasts; blocking ET-1
signaling might be a viable approach to controlling scarring in response to injury
in the skin.
Authors: James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown Journal: Nat Rev Mol Cell Biol Date: 2002-05 Impact factor: 94.444
Authors: A M Doherty; W L Cody; N L Leitz; P L DePue; M D Taylor; S T Rapundalo; G P Hingorani; T C Major; R L Panek; D G Taylor Journal: J Cardiovasc Pharmacol Date: 1991 Impact factor: 3.105
Authors: Xu Shi-Wen; Fernando Rodríguez-Pascual; Santiago Lamas; Alan Holmes; Sarah Howat; Jeremy D Pearson; Michael R Dashwood; Roland M du Bois; Christopher P Denton; Carol M Black; David J Abraham; Andrew Leask Journal: Mol Cell Biol Date: 2006-07 Impact factor: 4.272
Authors: A Kantarci; S A Black; C E Xydas; P Murawel; Y Uchida; B Yucekal-Tuncer; G Atilla; G Emingil; M I Uzel; A Lee; E Firatli; M Sheff; H Hasturk; T E Van Dyke; P C Trackman Journal: J Pathol Date: 2006-09 Impact factor: 7.996
Authors: Shi-wen Xu; Sarah L Howat; Elisabetta A Renzoni; Alan Holmes; Jeremy D Pearson; Michael R Dashwood; George Bou-Gharios; Christopher P Denton; Roland M du Bois; Carol M Black; Andrew Leask; David J Abraham Journal: J Biol Chem Date: 2004-03-23 Impact factor: 5.157
Authors: Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill Journal: Mol Pharmacol Date: 2002-07 Impact factor: 4.436
Authors: James Hutchenreuther; Krista M Vincent; David E Carter; Lynne-Marie Postovit; Andrew Leask Journal: J Invest Dermatol Date: 2015-07-13 Impact factor: 8.551
Authors: Sun Wook Kim; Ha Won Kim; Wei Huang; Motoi Okada; Jeffrey A Welge; Yigang Wang; Muhammad Ashraf Journal: Cardiovasc Res Date: 2013-09-25 Impact factor: 10.787
Authors: Andrea E Dillinger; Sabrina Kuespert; Franziska Froemel; Ernst R Tamm; Rudolf Fuchshofer Journal: Cell Tissue Res Date: 2021-01-29 Impact factor: 5.249